COVID-19 Trial - Immune Compromised Volunteers
ENG14/COVID-EDV Immunocompromised Vaccine Trial FAQ
Q: Is the COVID-EDV vaccine available to the general public?
A: While the COVID-EDV trial vaccine has been researched in healthy volunteers in a Phase I/IIa capacity, it is not available for general access beyond recruitment to trials. This current trial is specifically recruiting immunocompromised individuals.
Q: Where is the COVID-EDV Immunocompromised vaccine trial taking place?
A: The COVID-EDV immunocompromised vaccine trial is expected to begin recruitment in Melbourne by end of 2022, with Sydney and Perth to follow. Please contact the following email address for recruitment or eligibility enquiries:
Q: Is the COVID-EDV vaccine mRNA or adenovirus-based vaccine?
A: Neither. EnGeneIC’s vaccine uses its platform EDVTM (EnGeneIC Dream Vector) technology. EDVs are non-living “nanocells” carrying COVID-19 spike protein. The nanocell is further engineered to stimulate innate and adaptive immunity against SARS-CoV-2 virus via a completely different pathway. COVID-EDV vaccine comes with spike protein pre-packaged and does not use your body’s own cells to synthesize the spike protein.
Q: Is COVID-EDV pathogenic?
A: EnGeneIC EDV nanocells are non-pathogenic and are unable to infect nor replicate within your body. COVID-EDV vaccine does not contain the live virus that causes COVID-19. It has no ability to recreate SARS-CoV-2 virus in your body and it cannot make you sick with COVID-19.
Q: Does COVID-EDV vaccine contain fetal calf serum (FCS) or other animal-derived products?
A: COVID-EDV vaccine does not contain fetal calf serum (FCS), nor any other products of animal origin.
Q: Does COVID-EDV vaccine contain Foetal Cells, Human Embryonic Kidney Cells (HEKs) or other human-derived products?
A: COVID-EDV vaccine does not contain nor utilise HEKs, nor does it contain any other products of human origin.
Q: Does COVID-EDV vaccine contain preservatives/additives?
A: COVID-EDV vaccine does not contain any preservatives/additives. It is packaged as a dry powder and is made up prior to injection with sterile water.